CIK 0001531177 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800625749
- Phone
- (415) 889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-02 | Taylor Brenton EVP, Operations & R&D | Sale 10b5-1 | −2,988 | $8.85 | $26K | 261,990 |
| 2026-10-02 | Bauerlein Alison Chief Operating Officer | Sale 10b5-1 | −25,260 | $8.85 | $224K | 639,449 |
| 2026-10-02 | Rodberg James Chief Financial Officer | Sale 10b5-1 | −7,208 | $8.85 | $64K | 216,829 |
| 2026-10-01 | Badawi David Chief Technology Officer | Sale 10b5-1 | −7,797 | $9.05 | $71K | 1,975,075 |
| 2026-10-01 | Badawi Paul President and CEO | Sale 10b5-1 | −29,653 | $9.05 | $268K | 6,092,819 |
| 2026-08-10 | Rashid Kashif Chief Legal Officer | Grant or award | +181,818 | 181,818 | ||
| 2026-07-06 | HAYDEN JEREMY B. Chief Legal Officer | Sale 10b5-1 | −12,733 | $5.51 | $70K | 357,037 |
| 2026-07-06 | Badawi David Chief Technology Officer | Sale 10b5-1 | −7,418 | $5.51 | $41K | 1,982,872 |
| 2026-07-02 | Rodberg James Chief Financial Officer | Sale 10b5-1 | −6,902 | $5.36 | $37K | 224,037 |
| 2026-07-02 | Bauerlein Alison Chief Operating Officer | Sale 10b5-1 | −24,184 | $5.36 | $130K | 664,709 |
| 2026-07-01 | Taylor Brenton EVP, Operations & R&D | Sale 10b5-1 | −2,829 | $5.42 | $15K | 264,978 |
| 2026-07-01 | Badawi Paul President and CEO | Sale 10b5-1 | −28,684 | $5.42 | $155K | 6,122,472 |
| 2026-06-10 | Encrantz Staffan Director | Purchase | +14,100 | $4.88 | $69K | 1,434,283 |
| 2026-06-04 | Fountain Tamara Director | Grant or award | +28,261 | 109,650 | ||
| 2026-06-04 | Encrantz Staffan Director | Grant or award | +28,261 | 1,420,183 | ||
| 2026-06-04 | Burbach Gerhard F Director | Grant or award | +28,261 | 123,207 | ||
| 2026-06-04 | Zurbay Donald Director | Grant or award | +28,261 | 193,613 | ||
| 2026-06-04 | Mazzacco Catherine Director | Grant or award | +28,261 | 69,276 | ||
| 2026-05-18 | Bauerlein Alison Chief Operating Officer | Sale 10b5-1 | −12,728 | $5.12 | $65K | 688,893 |
| 2026-04-06 | Rodberg James Chief Financial Officer | Sale 10b5-1 | −7,231 | $3.55 | $26K | 230,939 |
Page 1 of 7 · 126 trades